Chromogranin a gene expression in non-small cell lung carcinomas

Journal of Pathology

Volumn 186, Issue 2, 1998, Pages 151-156

  Abbona, Giancarlo ^a   Papotti, Mauro ^a   Viberti, Laura ^a   Macrǐ, Luigia ^a   Stella, Anna ^a   Bussolati, Giannt ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Chromogranin A; Neuroendocrine; Non small cell lung carcinoma; RT PCR

Indexed keywords

CHROMOGRANIN A; LEUCINE; NEURON SPECIFIC ENOLASE; SYNAPTOPHYSIN;

ADULT; AGED; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; BLOTTING, NORTHERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL DIFFERENTIATION; CHROMOGRANIN A; CHROMOGRANINS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEUROSECRETORY SYSTEMS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0031671641     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(1998100)186:2<151::AID-PATH154>3.0.CO;2-7     Document Type: Article

References (23)

1. Linnoila I, Mulshine JL, Steinberg SM, et al. Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas. Am J Clin Pathol 1988; 90: 641-652.
2. Hamid Q, Corrin B, Sheppard MN, Huttner WB, Polak JM. Expression of chromogranin A mRNA in small cell carcinoma of the lung. J Pathol 1991; 163: 293-297.
3. Mooi WJ, Dingemans KP, Wagenar SS, et al. Ultrastructural heterogeneity of lung carcinomas: representativity of samples for electron microscopy in tumor classification. Hum Pathol 1990; 21: 1227-1234.
4. Mooi WJ, Dewar A, Springall D, et al. Non-small cell lung carcinomas with neuroendocrine features. A light microscopic, immunohistochemical and ultrastructural study of II cases. Histopathology 1988; 13: 329-337.
5. Linnoila RI, Piantadosi S, Ruckdeschel JC. Impact of neuroendocrine differentiation in non-small cell lung cancer. Chest 1994; 106 (Suppl 6): 367-371.
6. Schleusener JT, Tazelaar HD, Jung SH, et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. Cancer 1996; 77: 1284-1291.
7. Graziano SL, Tatum AH, Newman NB, et al. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 1994; 54: 2908-2913.
8. Loy TS, Darkow GV, Quesenberry JT. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas. An immunohistochemical study with ultrastructural correlations. Am J Surg Pathol 1995; 19: 173-182.
9. Linnoila RI, Jensen S, Steinberg S, et al. Neuroendocrine (NE) differentiation in non-small cell lung cancer (NSCLC) correlates with favorable response to chemotherapy (CT). Proc Am Soc Clin Oncol 1989; 8: 248.
10. Pagani A, Papotti M, Hofler H, Weiler R, Winkler H, Bussolati G. Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot and hybri̧dization analyses. Am J Pathol 1990; 136: 319-327.
11. Pagani A, Forni M, Tonini GP, Papotti M, Bussolati G. Expression of members of the chromogranin family in primary neuroblastomas. Diagn Mol Pathol 1992; 1: 16-24.
12. Pagani A, Papotti M, Abbona GC, Bussolati G. Chromogranin gene expressions in colorectal adenocarcinomas. Mod Pathol 1995; 8: 626-632.
13. The World Health Organization histological typing of lung tumors. 2nd ed Am J Clin Pathol 1982; 77: 123-136.
14. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Sorensen PHB, Shimada H, Liu XF, Lim JF, Thomas G, Triche TJ. Biphenotypic sarcomas with myogenic and neural differentiation express the Ewing's sarcoma EWS/FLI1 fusion gene. Cancer Res 1995; 55: 1385-1392.
17. Said JW, Vimadalal S, Nassh G, et al. Immunoreactive neuron-specific enolase, bombesin and chromogranin as markers for neuroendocrine lung tumors. Hum Pathol 1983; 14: 70-76.
18. Bergh J, Esscher T, Steinholtz L, Nillson K, Paohlman S. Immunocytochemical demonstration of neuron-specific enolase (NSE) in human lung cancers. Am J Clin Pathol 1985; 84: 1-7.
19. Kibbelaar RE, Moolenaar KEC, Michalides RJAM, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27: 431-435.
20. Sundaresan V, Reeve JC, Stenning S, Stewart S, Bleehen NM. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumors. Br J Cancer 1991; 64: 333-338.
21. Berendsen HH, de Leij L, Poppema PE, et al. Clinical characterization of non-small-cell lung cancer tumours showing neuroendocrine differentiation features. J Clin Oncol 1989; 11: 1614-1620.
22. Viberti L, Papotti M, Abbona GC, Celano A, Filosso PL, Bussolati G. Value of Ki-67 immunostaining in pre-operative biopsies of carcinomas of the lung. Hum Pathol 1997; 28: 189-192.
23. Ooi A, Hayashi H, Katsuda S, Nakanishi I. Gastric carcinoma cells with endocrine differentiation show no evidence of proliferation. Hum Pathol 1992; 23: 736-740.